Analyst Profile

Followed by 193 followers
.
Akash Tewari

Akash Tewari

Jefferies
Wall Street Analyst
#690 out of 8,141 Wall Street Analysts
#1,457 out of 24,284 experts

Success Rate

54%
39 out of 72 transactions made a profit

Average Return

+19.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Akash Tewari's trades since 2018 and holding each position for 1 Year would result in 54.17% of your transactions generating a profit, with an average return of 19.9% per rating.

Stock Rating Distribution

112Ratings
76.79% Buy
18.75% Hold
4.46% Sell
Distribution of Akash Tewari's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Biontech Se Sponsored Adr
(BNTX)
Rating:Buy
Date:Nov 05, 2019 - Nov 05, 2020
Return:+397.80%
The most profitable rating made by Akash Tewari

Akash Tewari's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
MDCO
Medicines Co
Dec 14, 2018
Buy
Initiated
1Ratings
100%
+341.80%
Teva Pharmaceutical
Jul 19, 2019
Hold
Initiated
$9.00
(1.47% Upside)
1Ratings
0.00%
ARQL
Arqule
Nov 05, 2019
Buy
Initiated
1Ratings
100%
+105.50%
Bausch Health Companies
Jan 29, 2020
Hold
Downgraded
2Ratings
100%
+25.70%
IGM Biosciences
Mar 12, 2020
Buy
Initiated
$75.00
(252.28% Upside)
1Ratings
100%
+137.10%
ALXN
Alexion Pharmaceuticals
Mar 12, 2020
Buy
Initiated
1Ratings
100%
+97.60%
Vertex Pharmaceuticals
Mar 12, 2020
Buy
Initiated
$282.00
(-9.90% Downside)
1Ratings
100%
+5.00%
Viatris
Feb 26, 2021
Hold
Downgraded
2Ratings
0%
-7.10%
XLRN
Acceleron Pharma
Oct 06, 2021
Hold
Initiated
2Ratings
0.00%
Zymeworks
Oct 06, 2021
Hold
Initiated
$32.00
(308.16% Upside)
2Ratings
100%
+26.40%
List of latest recommendations made by Akash Tewari. Click to expand and see Akash Tewari's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >